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In the core mammalian circadian negative feedback
loop, the BMAL1-CLOCK complex activates the tran-
scription of the genes Period (Per) and Crypto-
chrome (Cry). To close the negative feedback loop,
the PER-CRY complex interacts with the BMAL1-
CLOCK complex to repress its activity. These two
processes are separated temporally to ensure clock
function. Here, we show that histone deacetylase 3
(HDAC3) is a critical component of the circadian
negative feedback loop by regulating both the acti-
vation and repression processes in a deacetylase
activity-independent manner. Genetic depletion of
Hdac3 results in low-amplitude circadian rhythms
and dampened E-box-driven transcription. In sub-
jective morning, HDAC3 is required for the efficient
transcriptional activation process by regulating
BMAL1 stability. In subjective night, however,
HDAC3 blocks FBXL3-mediated CRY1 degradation
and strongly promotes BMAL1 and CRY1 associa-
tion. Therefore, these two opposing but temporally
separated roles of HDAC3 in the negative feedback
loop provide a mechanism for robust circadian
gene expression.INTRODUCTION
Eukaryotic circadian clocks consist of autoregulatory feedback
loops that regulate a wide variety of molecular and physiological
activities (Bass and Takahashi, 2010; Partch et al., 2014).
In the core mammalian circadian negative feedback loop, the
BMAL1-CLOCK complex is the positive element that activates
the transcription of Period (Per), Cryptochrome (Cry), andCclock-controlled genes by binding to E-boxes in their promoters.
In contrast, the PER-CRY complex is the negative element that
closes the negative feedback loop by repressing the activity of
the BMAL1-CLOCK complex (Hardin and Panda, 2013; Lowrey
and Takahashi, 2004; Reppert and Weaver, 2002; Schibler and
Naef, 2005). The cyclic activation and repression of E-box-driven
transcription is thought to be the major basis for endogenous
circadian rhythmicity in mammals (Lowrey and Takahashi, 2011).
BMAL1 is essential for circadian rhythm generation and is sub-
ject to multiple forms of post-translational modifications that are
important for its function (Bunger et al., 2000). BMAL1 is a sub-
strate for sumoylation, and thismodification is essential for circa-
dian clock oscillation (Cardone et al., 2005). More recently, it has
been shown that BMAL1 is also ubiquitylated and that BMAL1-
CLOCK activity is coupled tightly with the level of BMAL1 ubiq-
uitylation. First, transcriptional activation by BMAL1-CLOCK
correlates with high BMAL1 ubiquitylation levels (Lee et al.,
2008). Second, BMAL1-CLOCK, in association with the E-box-
containing Dbp promoter, is very unstable and shows a protea-
some-dependent fluctuation (Stratmann et al., 2012). In addition,
BMAL1 exhibits a robust circadian rhythm in phosphorylation
profiles (Tamaru et al., 2003, 2009), and it can be acetylated
by CLOCK and de-acetylated by the nicotinamide adenine
dinucleotide (NAD)+-dependent SIRT1 enzyme (Hirayama
et al., 2007; Nakahata et al., 2008).
The repression of the BMAL1-CLOCK complex by PER-CRY is
mediated by their interaction (Kiyohara et al., 2006; Nangle et al.,
2014; Partch et al., 2014; Ye et al., 2011), which peaks in the sub-
jective night around circadian time (CT) 15–18 (Lee et al., 2001).
In the PER-CRY complex, CRYs are thought to be the major re-
pressors (Griffin et al., 1999; Kume et al., 1999; Langmesser
et al., 2008; Ye et al., 2014). Although PER has been shown to
promote the BMAL1-CRY interaction (Chen et al., 2009), the
potent ability of CRY1 to repress BMAL1-CLOCK-induced tran-
scription in the absence of PERs was observed under different
systems (Partch et al., 2014; Shearman et al., 2000; Ye et al.,
2014). Recent studies have shown that PER may compete withell Reports 14, 823–834, February 2, 2016 ª2016 The Authors 823
FBXL3 to bindCRYs and, therefore, stabilize CRYs (Nangle et al.,
2014; Xing et al., 2013), and PERmay also counteract CRY func-
tion by maintaining CLOCK phosphorylation (Matsumura et al.,
2014). These findings suggest that PER proteins have multiple
effects on the circadian clock and CRYs (Brown et al., 2005; Du-
ong et al., 2011; Duong and Weitz, 2014; Koike et al., 2012; Miki
et al., 2012; Padmanabhan et al., 2012). CRYs are ubiquitylated
by two competing E3 ligase complexes containing the substrate
receptors FBXL3 and FBXL21 and are degraded by the protea-
some pathway (Busino et al., 2007; Hirano et al., 2013; Siepka
et al., 2007; Xing et al., 2013; Yoo et al., 2013). The degradation
of CRY allows the reactivation of the BMAL1-CLOCK complex
and the re-initiation of CRY and PER transcription in the subjec-
tive morning.
In addition to the core negative feedback, a secondary
feedback loop consists of the orphan nuclear receptors REV-
ERBa/b and retinoid-related orphan receptor (RORs), which
act on the Rev-Erb/ROR-binding element (RREs) to regulate
Bmal1 and Cry1 expression (Preitner et al., 2002; Sato et al.,
2004; Ueda et al., 2005; Ukai-Tadenuma et al., 2011). REV-
ERBa/b recruits the nuclear receptor corepressor (N-CoR) and
histone deacetylase 3 (HDAC3) to regulate homeostasis be-
tween circadian clock and metabolic pathways (Alenghat et al.,
2008; Yin and Lazar, 2005). HDAC3 is recruited by REV-ERBa
to direct genome-wide rhythmic histone acetylation and to
mediate circadian clock output pathways (Feng et al., 2011;
Yin and Lazar, 2005).We found recently that deletion of Fbxl3 im-
pairs the REV-ERBa-HDAC3-mediated suppression of Bmal1
and Cry1 transcription (Shi et al., 2013). Although HDAC3 is pri-
marily known to function as a deacetylase, and the crystal struc-
ture of HDAC3 and its co-repressor N-CoR2 suggests that
HDAC3 also likely serves to stabilize protein-protein interactions
(Watson et al., 2012). Consistent with this model, a deacetylase-
independent function of HDAC3 in transcription and metabolism
has been reported recently (Sun et al., 2013).
Here we demonstrate that HDAC3, in addition to regulating
rhythmic transcription via histone deacetylation, is a critical
component of the core circadian negative feedback loop inde-
pendent of its deacetylase activity. The genetic depletion of
HDAC3 results in low-amplitude circadian rhythms of E-box-
driven genes. During the subjective morning, HDAC3 promotes
BMAL1-dependent transcriptional activation. To close the nega-
tive feedback loop, HDAC3 facilitates the association between
BMAL1 and CRY1 during subjective night. Therefore, these
two temporally separate roles of HDAC3 act on both positive
and negative processes of the negative feedback loop to achieve
robust circadian gene expression.
RESULTS
Genetic Depletion of Hdac3 Severely Reduces the
Amplitude of Circadian Rhythms
To understand the role of Hdac3 in the mammalian circadian
clock, we generated a conditional knockout mouse line termed
Hdac3tm1a(EUCOMM)Wtsi (Hdac3f/f) using the European Conditional
Mouse Mutagenesis Program (EUCOMM) Embryonic Stem Cell
Resource (Figure 1A). Because whole-body deletion of Hdac3
results in very early embryonic lethality (Bhaskara et al., 2008),824 Cell Reports 14, 823–834, February 2, 2016 ª2016 The AuthorsAlb-Cre (Cre recombinase transcription under the control of
the Albumin promoter) mice were crossed with Hdac3f/f mice
to generate liver-specific Hdac3 knockout mice (Alb; Hdac3f/f)
(Knutson et al., 2008). Alb-Cre is expressed in parenchymal liver
cells, resulting in roughly 40% recombination hepatocytes at
birth and almost complete recombination by 2 weeks after birth
(Postic and Magnuson, 2000). Western blot analysis revealed
that the expression of HDAC3 was reduced markedly but not
abolished completely in the liver lysate from the Alb; Hdac3f/f
mice, potentially because of non-hepatocyte cells in the liver tis-
sue (Figure 1B).
To determine the role of HDAC3 in clock function, we crossed
Alb; Hdac3f/mice to Hdac3f/f;mPER2Luc knockin reporter mice
(Yoo et al., 2004) and monitored Per2-luciferase oscillation in
liver tissues. As shown in Figure 1C, in contrast to the robust
circadian bioluminescence rhythms in control Hdac3f/f mouse
liver tissues, the Alb; Hdac3f/f liver displayed an apparent lower
amplitude in bioluminescence rhythms. The normalized ampli-
tude of Alb; Hdac3f/f strain was significantly lower than that of
Hdac3f/f mouse liver from three independent experiments. This
result indicates that the reduction of HDAC3 expression in the
liver severely affected clock function. In contrast, normal circa-
dian bioluminescence rhythms were observed in lung and
suprachiasmatic nucleus (SCN) explants of Alb; Hdac3f/f mice,
in which Hdac3 expression is present (Figure S1).
To further confirm the role of HDAC3, we constitutively overex-
pressed HDAC3 or GFP in mouse embryonic fibroblasts (MEFs)
isolated from mPER2Luc embryonic day (E) 13.5–E14.5 mouse
embryos by infecting the cells with recombinant adenovirus ex-
pressing HDAC3 (Ad-HDAC3) or GFP (Ad-GFP) under control of
the cytomegalovirus (CMV) promoter (Yoo et al., 2004). Western
blot analysis of whole-cell extracts showed that infectionwith the
Ad-HDAC3 virus resulted in elevated HDAC3 levels (Figure 1D,
right). The constitutive elevation of Hdac3 expression in the
mPER2Luc MEFs increased the amplitude of the biolumines-
cence oscillation of Per2-luciferase (Figure 1D). Together, these
results indicate that HDAC3 plays a critical role in maintaining
high-amplitude circadian gene expression.
Depletion of Hdac3 Affects Circadian Gene Expression
and Results in Low BMAL1 and CRY Protein Levels
We then examined the levels of clock gene expression in Alb;
Hdac3f/f liver tissues. RNA was prepared at various circadian
time points in the Hdac3f/f (hereafter referred to as wild-type
[WT]) and Alb; Hdac3f/f (knockout) liver tissues. As shown in
Figure 2A, depletion of Hdac3 resulted in significant reductions
in the peak transcript levels of E-box-driven genes such as
Per1, Per2, Cry2, and Dbp (Figure 2A). Although Cry1 transcrip-
tion is driven by E-box, which should be reduced by the deple-
tion of Hdac3, such an effect can be counterbalanced by the
derepression of RRE-driven transcription. As a result, Cry1
mRNA levels were not affected by the depletion of Hdac3.
The N-CoR/HDAC3 complex has been shown previously to
be recruited by REV-ERBa to repress RRE-driven gene tran-
scription (Yin and Lazar, 2005). However, knockout of Hdac3
does not completely phenocopy the Rev-Erbamutant, suggest-





Figure 1. HDAC3 Is Required for High-
Amplitude Circadian Rhythms of Per2-
Luciferase
(A) Schematic of the targeting strategy for Hdac3-
floxed mice. Targeted ESC colonies obtained from
EUCOMMwere used for blastocyst injections. The
mice that retained the loxP sites flanking exon 3 at
the endogenousHdac3 locuswere bred toAlb-Cre
mice in a C57BL/6N background to generate liver-
specific knockout mice.
(B) Immunoblot with anti-HDAC3 antibody
showing the depletion of the HDAC3 protein inAlb;
Hdac3f/f liver tissues.
(C) Left: representative bioluminescence signals
from liver slices of Hdac3f/f; Per2luc (blue) and Alb;
Hdac3f/f; Per2luc (red) mice. Right: normalized
amplitudes between cycles 2 and 4 were calcu-
lated as described in the Experimental Pro-
cedures. Means ± SD are shown (Hdac3f/f; Per2luc,
10 slices; Alb; Hdac3f/f; Per2luc, 12 slices from
three independent experiments). **p < 0.001,
Student’s t test.
(D) Left: Per2luc MEFs were infected with either
GFP-expressing (blue) or HDAC3-expressing (red)
adenovirus for 60 hr and synchronized by a
dexamethasone shock. The effect of Hdac3
overexpression was determined using an immu-
noblot assay (bottom right). The asterisk indicates
non-specific bands (only seen in MEFs but not in
liver). Right: normalized amplitudes (n = 8 from
three independent experiments) of the rhythms.
**p < 0.001, Student’s t test.Despite their near-normal transcript levels, the BMAL1 and
CRY1 protein levels were decreased markedly in Alb; Hdac3f/f
livers (Figure 2B). In contrast to the accumulation of PER2 from
CT 12–24 in WT mice, PER2 only accumulated at CT 16 and
CT 20 in Alb; Hdac3f/f livers, but its rhythm was still robust. It
should be noted that PER2 rhythmicity here is likely driven by
systemic clues that can drive robust circadian rhythms in liver
gene expression even when the hepatic molecular clock is dis-
rupted (Kornmann et al., 2007).
We also obtained Hdac1 and Hdac2 conditional knockout
mouse lines (Hdac1tm1a(EUCOMM)Wtsi and Hdac2tm1a(EUCOMM)Wtsi)
from the International Mouse Phenotyping Consortium to
examine whether HDAC1 and HDAC2 have similar functions.
Thesemice were crossed toAlb-Cremice to obtain liver-specific
knockout mice (Alb; Hdac1f/f and Alb; Hdac2f/f mice). As shown
in Figures 2C and 2D, the genetic ablation ofHdac1 orHdac2 did
not have significant effects on the levels of BMAL1 and CRY1 inCell Reports 14, 823–834liver tissues as HDAC3 did, suggesting
that these HDACs play different roles.
HDAC3 Increases Enrichment of
BMAL1 on E-boxes
The effect of HDAC3 on E-box-driven
gene expression and on the abundance
of BMAL1 prompted us to compare the
enrichment of BMAL1 bound to Dbp
E-box in the promoter (Ripperger andSchibler, 2006) and E-box of Per2 genes (Yoo et al., 2005) in
WT and Alb; Hdac3f/f livers. Chromatin immunoprecipitation
(ChIP) assays revealed that the circadian rhythm of BMAL1
recruitment to E-boxes was impaired markedly in the Alb;
Hdac3f/f liver (Figure 3A). Importantly, depletion ofHdac3 only re-
sulted in a reduction of BMAL1 association with E-boxes around
the peak binding phases, when E-box-driven gene expression is
maximally activated by the BMAL1-CLOCK complex (Figure 3A).
To determine whether HDAC3 is important for the recruitment
of BMAL1 to E-box-driven genes, we infected MEFs with an
adenovirus expressing HDAC3 or GFP for 48 hr and collected
cells 15 and 24 hr after dexamethasone (DEX) treatment, which
corresponded to the peak and trough time points of E-box tran-
scriptional activity, respectively (Lee et al., 2008). ChIP assays
using anti-BMAL1 antibody showed that HDAC3 expression
dramatically enhanced the association of BMAL1 with the Dbp




Figure 2. mRNA and Protein Expression
Levels of Clock Genes in WT and Hdac3
Mutant Mice
(A) The expression levels of the Per1, Dbp, Per2,
Cry1, Cry2, and Bmal1 genes in WT (Hdac3f/f)
(blue) and Alb; Hdac3f/f (red) liver tissues were
measured by qRT-PCR and normalized to Gapdh
expression. The expression levels were plotted as
a.u., and the highest value in the sample was set to
1.0. Each value represents the mean ± SD (n = 3)
from three mice.
(B) Protein profiles of HDAC3, BMAL1, CRY1,
CRY2, and PER2 in total extracts fromWT andAlb;
Hdac3f/f liver tissues of 6- to 8-week-old mice.
Tubulin was used as the loading control. Each
image shows a representative example from three
independent experiments. All of the tissues were
collected at 4-hr intervals during the first day in
constant darkness (DD). The samples and blots
were processed in parallel in paired experiments.
In this and all following figures, gray bars represent
each subjective day, and the black bars represent
subjective night. The extra protein band (indicated
by an asterisk) above CRY1 is likely a non-specific
band because it cannot be immunoprecipitated by
an anti-CRY1 antibody.
(C and D) Circadian profiles of the BMAL1 and
CRY1 proteins in WT, Alb; Hdac1f/f (C) and Alb;
Hdac2f/f (D) liver tissues. Actin was used as the
loading control.phase (Dex 15) (Figure 3B). In contrast, HDAC3 expression had
no effect at the Dex 24 time point (Figure 3B), indicating that
the effect of HDAC3 on promoting BMAL1 recruitment is circa-
dian-regulated and is mostly limited to the E-box transcriptional
activation phase.
To examine whether the increased HDAC3-induced enrich-
ment of BMAL1 contributes to the transcription of E-box-driven
genes, we used DEX to entrain MEFs overexpressing Ad-GFP or
Ad-HDAC3 for 48 hr. The expression levels of endogenous
Hdac3, Dbp, and Per2 were determined at various circadian
time points. The overexpression of HDAC3 significantly
increased the amplitudes of the circadian rhythms of the Dbp
and Per2 mRNAs, indicating that increased enrichment of
BMAL1 to E-boxes by HDAC3 is important for the amplitude of
transcript rhythms (Figure 3C). Surprisingly, expression of a de-
acetylase-dead HDAC3 mutant (H134Q/H135A/A136S) (Wen
et al., 2003) had the same effects asWTHDAC3 (Figure 3C), indi-
cating that this role of HDAC3 in the circadian clock is indepen-
dent of its histone deacetylase function. Together, these results
demonstrate that HDAC3 acts in the positive limb of the circa-
dian negative feedback loop in a histone deacetylase-indepen-
dent manner. HDAC3 functions by maintaining BMAL1 levels
during the activation phase of E-box-driven circadian gene
expression.
HDAC3 Associates with BMAL1 and Promotes
BMAL1 Ubiquitylation
To determine how BMAL1 is regulated by HDAC3, we examined
whether BMAL1 and HDAC3 associate in cells. HEK293T cells
were transfected with constructs expressing hemagglutinin826 Cell Reports 14, 823–834, February 2, 2016 ª2016 The Authors(HA)-HDAC3 and FLAG-BMAL1. Immunoprecipitation assays
showed the presence of HDAC3 in the anti-BMAL1 pull-down
complexes (Figure 4A, top, lane 3). BMAL1 was also detected
in the reciprocal pull-downs using anti-HA (HDAC3) antibody
(Figure 4A, top, lane 6). No band was observed in the control
samples.
Co-immunostaining of endogenous BMAL1 and HDAC3 in
MEFs was also consistent with the interaction of HDAC3 with
endogenous BMAL1 (Figure S2A). BMAL1 primarily localized to
the nucleus. Although HDAC3 was found in both the nucleus
and cytoplasm, it colocalized with BMAL1 in the nucleus (Fig-
ure S2A). Together, these results demonstrate that HDAC3 asso-
ciates with BMAL1.
It has been suggested previously that BMAL1-CLOCK ubiqui-
tylation is critical for the transcriptional activity of the complex
(Lee et al., 2008; Stratmann et al., 2012). The reduced level of
BMAL1 in Alb; Hdac3f/f liver tissue prompted us to examine the
role of HDAC3 in this process. We found that HDAC3 expression
markedly increased the amount of ubiquitylated BMAL1 (Fig-
ure 4B, lanes 2 and 6). The increase was even more pronounced
when MG132 treatment was used to inhibit proteasome-medi-
ated degradation (Figure 4B, lanes 4 and 8), suggesting that
HDAC3 promotes BMAL1 ubiquitylation.
To confirm our observations in vivo, we compared the levels of
ubiquitylated BMAL1 in the liver tissues of WT and Alb; Hdac3f/f
mice at different circadian time points. As expected, the levels of
ubiquitylated BMAL1 were reducedmarkedly in the Alb;Hdac3f/f
liver (Figure 4C). Notably, the most pronounced decrease in
ubiquitylated BMAL1 levels in Alb; Hdac3f/f mice occurred
around the peak time points (CT 4–12) that correspond to the
A B
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Figure 3. HDAC3 Enhances the Enrichment
of BMAL1 at the E-box during the Activation
Phase and Increases the Amplitudes of Dbp
and Per2 mRNA Rhythms
(A) BMAL1 binding to the E-box regions of the
Per2 and Dbp promoters during a circadian cycle
(mean ± SD, n = 3) in WT (black) and Alb; Hdac3f/f
(gray) livers. **p < 0.001, Student’s t test. IgG
served as an internal control. Chromatin samples
from mouse livers were analyzed using ChIP
with anti-BMAL1 antibodies. ChIP primers are
described in Table S1.
(B) Synchronized WT MEFs were infected with
adenoviruses overexpressing either GFP or
HDAC3. Enrichment of BMAL1 at the Per2 or Dbp
promoters was detected by chromatin immuno-
precipitation (IP) with anti-BMAL1 antibodies at
the indicated time points (mean ± SD, n = 3; **p <
0.001, Student’s t test). IgG, immunoglobulin G.
(C) The expression levels of Dbp, Per2, and Hdac3
in WT MEFs infected with adenoviruses carrying
GFP, HDAC3, or an HDAC3 mutant were
measured by qRT-PCR and normalized to Gapdh
expression. The MEFs were synchronized with a
DEX shock and collected in a time course manner.
The expression levels were plotted in a.u. Each
value represents the mean ± SD (n = 3). Two-way
ANOVA shows significant statistical differences
(p < 105) between GFP and HDAC3 or HDAC3
(H134Q/H135A/A136S) samples.peak of BMAL1 binding to E-boxes (Figure 3A). These results
indicate that, during the E-box activation phase, HDAC3 pro-
motes BMAL1 ubiquitylation, which is known to be associated
with the peak activity of the BMAL1-CLOCK complex (Kwon
et al., 2006; Lee et al., 2008). Together, these results suggest
that HDAC3 associates with BMAL1 and regulates the tran-
scriptional activation activity of the BMAL1-CLOCK complex
by promoting its ubiquitylation, which likely results in BMAL1
stabilization.
HDAC3 Blocks FBXL3-Mediated CRY1 and CRY2
Degradation
The reduced CRY1 protein levels but near-normal Cry1 mRNA
levels in Alb; Hdac3f/f mice prompted us to examine the mecha-
nism by which HDAC3 regulates CRY1 abundance. We first
examined whether HDAC3 physically associates with CRY1 in
cells. HEK293T cells were transfected with constructs express-
ing HA-HDAC3 and HA-CRY1 and were then immunoprecipi-
tated with a CRY1 antibody. As shown in Figure 5A, little
HDAC3 was detected in the CRY1 immunoprecipitates (Fig-
ure 5A, lane 1), suggesting that the association between
HDAC3 and CRY1 is weak or transient. Surprisingly, when
FBXL3 was co-expressed in these cells, abundant HDAC3 was
found to be associated with CRY1 (Figure 5A, lane 2). FBXL3 is
part of the E3 ligase that mediates the ubiquitylation and degra-
dation of CRY1 (Busino et al., 2007; Siepka et al., 2007). The
FBXL3-dependent increase in the HDAC3-CRY1 interaction
occurred despite the decrease in CRY1 protein levels (Figure 5A,
input lane 2). This effect of FBXL3 is dependent on its E3 ligase
activity because expression of FBXL3 lacking its F-boxC(FBXL3DF-box: F-box deletion form) had no effect on the
HDAC3-CRY1 interaction (Figure 5A, lane 3).
The ability of FBXL3 to promote an association between
HDAC3 and CRY1 raises the possibility that HDAC3may interact
with FBXL3, a process that may affect CRY stability. HEK293
cells were transfected with constructs expressing FLAG-
FBXL3 andHA-HDAC3.We found that FBXL3 coimmunoprecipi-
tated with HDAC3 (Figure 5B). Consistent with this result, immu-
nofluorescence analysis showed that FBXL3 and HDAC3 colo-
calized within the nucleus of HEK293T cells (Figure S2B). To
examine the FBXL3 andHDAC3 interaction in vivo, we generated
a bacterial artificial chromosome (BAC) transgenic mouse line
encoding a FLAG and hemagglutinin (HA) N terminus-tagged
Fbxl3 gene (FH-FBXL3) (Figure 5C). The FH-FBXL3 BAC trans-
genic mice showed normal circadian rhythms (data not shown).
The lysates of the FH-FBXL3 liver were then subjected to coim-
munoprecipitation with a FLAG antibody. As shown in Figure 5C,
HDAC3 was detected in the FLAG immunoprecipitates, indi-
cating that HDAC3 and FBXL3 associate in vivo.
Because FBXL3 interacts with CRY1 to mediate its ubiquityla-
tion and subsequent degradation, the association between
HDAC3 and FBXL3 may, therefore, interfere in this process. To
test this possibility, we compared the degradation rate of
CRY1 in the presence of cycloheximide (CHX) to block de
novo protein synthesis 24 hr after transfection of Bmal1 and
Cry1, Fbxl3, or Hdac3 expression vectors in HEK293T cells.
Similar to previous reports (Busino et al., 2007; Siepka et al.,
2007), CRY1 underwent rapid degradation in the presence of
FBXL3 (Figure 5D, center). However, the expression of HDAC3
almost completely blocked CRY1 degradation, even whenell Reports 14, 823–834, February 2, 2016 ª2016 The Authors 827
AB
C Figure 4. HDAC3 Promotes the Ubiquityla-
tion of BMAL1
(A) The interaction between FLAG-BMAL1 and
HA-HDAC3 was measured using IPs in HEK293T
cells. Reciprocal IPs were performed with anti-
BMAL1 (left) or anti-HA (right) antibodies. Subse-
quent detection of HDAC3 or BMAL1 was per-
formed using anti-HA or anti-FLAG antibodies.
WB, western blot.
(B) In vivo ubiquitylation assay of BMAL1.
HA-HDAC3 and HA-BMAL1 were expressed in
HEK293T cells. Twenty-four hours after trans-
fection, the cells were treated with either 20 mM
MG132 or DMSO (solvent) for 6 hr. The ubiq-
uitylation of BMAL1 purified with anti-BMAL1
antibody was detected with antibodies against
BMAL1 and ubiquitin (Ub).
(C) Liver lysates were collected at the different time
points for each genotype and were then subjected
to IP with an anti-BMAL1 antibody. Immunopre-
cipitates were blotted with an anti-ubiquitin anti-
body. BMAL1 purified with an anti-BMAL1 anti-
body was detected with an antibody against
BMAL1. Bottom: the relative levels of ubiquitylated
BMAL1 (quantified with NIH ImageJ software) in
WT and Alb; Hdac3f/f liver tissues. Two-way
ANOVA shows significant statistical differences
between the two groups (p < 104).FBXL3 was overexpressed (Figure 5D, right). These results
suggest that HDAC3 interferes with FBXL3-mediated CRY1
degradation.
To determine the mechanism by which HDAC3 interferes
with CRY1 degradation, we expressed HA-CRY1, HA-HDAC3,
FBXL3, or FBXL3DF-box in HEK293T cells. Interestingly, co-
expression of HDAC3 with CRY1 resulted in a marked accumula-
tion of ubiquitylated CRY1 in the immunoprecipitate (Figure 5E,
lanes 2 and 8). The level of immunoprecipitated, ubiquitylated
CRY1 was increased further when FBXL3, but not FBXL3DF-box,
was coexpressed (Figure 5E, lanes 4, 6, 10, and 12). In addition,
HDAC3 and exposure to MG132 showed strong synergistic ef-
fects in promoting the accumulation of ubiquitylated CRY1 (Fig-
ure S3). Because the abundance of CRY2 protein was also
decreased in Alb; Hdac3f/f mice, we performed parallel experi-
ments with CRY2. We found that HDAC3 also promoted CRY2
ubiquitylation (Figure S4A) and protected FBXL3-mediated
CRY2 degradation (Figure S4B). Taken together, these results
suggest that HDAC3 blocks CRY protein degradation by inter-
fering with the degradation of ubiquitylated CRY proteins.
HDAC3 Promotes the Assembly of the BMAL1-CRY1
Complex during the Repression Phase
CRY transcriptionally represses the mammalian circadian nega-
tive feedback loop by interacting with the BMAL1-CLOCK com-
plex (Lee et al., 2001; Yagita et al., 2002; Ye et al., 2014). The abil-
ity of HDAC3 to interact with BMAL1 and to associate with CRY1
in the presence of FBXL3 raises the possibility that HDAC3 and
FBXL3 are involved in sequential assembly steps of the
repressor complex in the circadian negative feedback process.828 Cell Reports 14, 823–834, February 2, 2016 ª2016 The AuthorsTo test this hypothesis, we transfected HEK293T cells with
FLAG-tagged BMAL1, HA-tagged CRY1, and different combina-
tions of HA-tagged HDAC3 and FBXL3. Very little BMAL1-CRY1
association was detected when Bmal1 was coexpressed with
Cry1 (Figure 6A, lane 1). Remarkably, the expression of
HDAC3, but not FBXL3, dramatically increased the BMAL1 and
CRY1 association (Figure 6A, lane 4 versus lane 2). However,
further addition of FBXL3 substantially enhanced the effect of
HDAC3 on BMAL1-CRY1 association in an E3 ligase activity-
dependent manner (Figure 6A, lane 5 versus lane 6), suggesting
that ubiquitylation is important for the association. In contrast,
the expression of FBXL21 (Hirano et al., 2013; Yoo et al., 2013)
had no such effect (Figure 6A, lanes 7 and 8). These findings sug-
gest that HDAC3 and FBXL3 promote association between
BMAL1 and CRY1.
To confirm this conclusion in vivo, we examined the associa-
tion between BMAL1 and CRY1 in the liver tissues of Fbxl3
knockout and Alb; Hdac3f/f mice. As shown in Figure 6B, in the
WT tissue, there was a robust rhythm of BMAL1-CRY1 associa-
tion that peaked during subjective night, which corresponds to
the transcriptional repression phase of E-box-driven genes.
Although the levels of CRY1 and BMAL1 were similar at different
time points in WT and Fbxl3/ liver extracts, the association be-
tween BMAL1 and CRY1 was reduced significantly in Fbxl3/
liver extracts (Figures 6B and 6C). Similarly, we found that the
BMAL1-CRY1 association was reduced dramatically in Alb;
Hdac3f/f liver extracts (Figures 6D and 6E).
Notably, in both the Alb; Hdac3f/f and the Fbxl3/ liver ex-
tracts, the reduction in BMAL1-CRY1 association occurred pri-





Figure 5. HDAC3 Blocks FBXL3-Mediated
CRY1 Degradation
(A and B) The interactions between HDAC3 and
CRY1 (A) and HDAC3 and FBXL3 (B) were de-
tected using a similar strategy as in Figure 4A.
(C) The endogenous interaction between FBXL3
andHDAC3was detected using an IP strategywith
the indicated antibodies. The IPs were performed
at two different time points (CT 0 and CT 12) using
FH-FBXL3 BAC transgenic liver tissues. A sche-
matic of the FH-FBXL3 BAC transgenic mice is
shown at the top.
(D) The effects of HDAC3 on CRY1 stability. HA-
CRY1, FBXL3, and BMAL1 were cotransfected
with or without HA-HDAC3. Twenty-four hours
after transfection, 20 mg/ml of CHX was added and
incubated with the cells for the indicated time.
Cell lysates were subjected to immunoblotting
with the indicated antibodies, and actin was used
as a loading control.
(E) In vivo ubiquitylation assay. HEK293T cells
were transfected with HA-HDAC3, HA-CRY1, and
FBXL3 or an F-box-deleted form of FBXL3
(DF-box). Twenty-four hours after transfection, the
cells were lysed. MG132 treatment is shown in
Figure S2. The ubiquitylation of CRY1 purified with
anti-CRY1 antibody was detected with an anti-
body against CRY1 and Ubiquitin.interaction with and inhibition of the BMAL1-CLOCK complex.
Together, these observations suggest that HDAC3 mediates
the BMAL1-CRY1 interaction by blocking the degradation of
CRY1 and promoting BMAL1-CRY1 interaction during the
repressive phase, a process that inhibits the BMAL1-CLOCK
complex. Therefore, HDAC3 has two seemly opposite roles
in the circadian negative feedback loop: influencing both tran-
scriptional activation and repression. The temporal separation
of these two roles of HDAC3 ensures robust circadian gene
expression.
The Effect of HDAC3 on BMAL1 and CRY1 Is
Independent of Its Deacetylase Activity and PER2
We found that mutations of HDAC3 (H134Q/H135A/H136S or
S424A) that abolished its deacetylase activity (Wen et al.,
2003; Zhang et al., 2005) did not affect its ability to interact
with BMAL1, CRY1, or FBXL3 (Figures S5A–S5F) or to promote
BMAL1 ubiquitylation (Figure 7A). In addition, treatment withCell Reports 14, 823–834the pan-HDAC inhibitor trichostatin A
(TSA) also did not affect the ability of
HDAC3 to promote the association be-
tween BMAL1 and CRY1 (Figure S6A).
Furthermore, TSA treatment did not pro-
tect CRY1 from degradation (Figure S6B,
4). In contrast, overexpression of WT or
catalytically dead HDAC3 was able to
inhibit FBXL3-mediated CRY1 degrada-
tion (Figure S6B, 5 and 6) and to promote
ubiquitylation of CRY1 (Figure S6C). More
importantly, the overexpression of cata-lytically dead HDAC3 markedly increased the amplitude of
Per2-luciferase oscillation in MEFs (Figure 7B). Together, these
results indicate that the effect of HDAC3 on BMAL1 and CRY1
is independent of its deacetylase activity.
Similar to the roles of HDAC3 shown in this work, PER2 has
also been shown to mediate the interaction between CRY1
and the BMAL1-CLOCK complex and to prevent CRY1 protein
degradation (Chen et al., 2009; Yagita et al., 2002). To compare
the role of PER2 and HDAC3, we expressed FLAG-tagged
BMAL1, HA-tagged CRY1, and different combinations of HA-
tagged HDAC3, PER2, and FBXL3 in HEK293T cells. BMAL1
immunoprecipitation showed that more CRY1 was immunopre-
cipitated with HDAC3 expression than with PER2 expression,
despite the input level of CRY1 being higher in cells expressing
PER2 than in cells expressing HDAC3 (Figure 7C, input lanes 3
and 7). Notably, additional FBXL3 expression did not enhance
the association between BMAL1 and CRY1 when PER2 was ex-




Figure 6. HDAC3 Promotes the Interaction
between BMAL1 and CRY1 in a FBXL3-
Dependent Manner
(A) The interactionsbetweenFLAG-BMAL1andHA-
CRY1 were measured in the presence or absence
of cotransfected HA-HDAC3, FBXL3, FBXL3 (DF-
box), or FLAG-FBXL21 in HEK293T cells. IPs were
performed with an anti-BMAL1 antibody, and the
subsequent detection of CRYs and HDAC3 was
conducted with an anti-HA antibody.
(B) Circadian profiles of the association between
BMAL1 and CRY1 in the livers of WT (left) and
Fbxl3/ (right) mice. BMAL1 purified with anti-
BMAL1 or CRY1 purified with anti-CRY1 was de-
tected by antibodies against BMAL1 or CRY1. The
protein profiles of BMAL1 and CRYs in total ex-
tracts served as the input controls.
(C) The average intensities of the indicated proteins
as assayed by densitometry of triplicate blots
(mean ± SD). The highest intensity among the
sampleswithin a single blot was set as 1.0 andwas
normalized using the immunoprecipitated BMAL1
or CRY1 intensity. Two-way ANOVA shows signif-
icant statistical differences between WT and
Fbxl3/ mice for the immunoprecipitated CRY1
andBMAL1 (p< 105 andp<0.0001, respectively).
(D) Circadian profiles of the BMAL1-CRY interac-
tion in WT and Alb; Hdac3f/f liver tissues. Recip-
rocal IP and subsequent WB analyses were per-
formed with the indicated antibodies. BMAL1
purified with anti-BMAL1 antibodies or CRY1 pu-
rified with anti-CRY1 antibodies was detected
with antibodies against BMAL1 or CRY1. Fig-
ure 2B shows the input for BMAL1 and CRY1.
(E) Quantified data were obtained and are shown
as described in (C). Two-way ANOVA shows sig-
nificant statistical differences between WT and
Alb; Hdac3f/f mice for the immunoprecipitated
CRY1 and BMAL1 (p < 0.0001 and p < 0.001,
respectively).of FBXL3 when HDAC3 is expressed (Figure 6A). Furthermore,
PER2 expression did not increase ubiquitylated CRY1 levels in
the absence or presence of FBXL3 (Figure 7D). These results
demonstrate that the role of HDAC3 in mediating the BMAL1-
CRY1 interaction differs from and is independent of PER2.
These results provide a likely mechanism for the ability of
CRY1 to inhibit BMAL1-CLOCK-driven E-box transcription in
the absence of PER proteins (Shearman et al., 2000; Ye et al.,
2011, 2014).
DISCUSSION
Cyclic activation and repression of E-box-driven transcription is
the primary basis for circadian gene expression. In this study, we
showed that liver-specific depletion of Hdac3 led to low-ampli-
tude rhythms and dampened E-box-driven transcription. In
contrast, cellular overexpression of HDAC3 greatly increased
the amplitude of Per2-luciferase rhythms. These results indicate
that HDAC3 is critical for clock function.
Our results demonstrate HDAC3 is a critical component of
the circadian negative feedback loop that regulates both tran-
scriptional activation and repression processes in a deacety-830 Cell Reports 14, 823–834, February 2, 2016 ª2016 The Authorslase activity-independent manner. HDAC3 achieves these func-
tions through two distinct mechanisms. During the activation
phase, when E-box-driven transcription is maximally activated,
HDAC3 promotes enrichment of BMAL1 at the E-box, likely by
stabilizing BMAL1. In Alb; Hdac3f/f mouse liver tissues, the as-
sociation of BMAL1 with E-boxes was reduced significantly
from CT 8–12, explaining the reduced peak transcription levels
of E-box-driven genes (Figure 3A). In contrast, overexpression
of HDAC3 enhanced BMAL1 recruitment to the E-box (Fig-
ure 3B) and increased the peak levels of Per2 and Dbp tran-
scripts (Figure 3C).
The peak activity of the BMAL1-CLOCK complex is correlated
tightly with BMAL1 ubiquitylation (Lee et al., 2008; Stratmann
et al., 2012), suggesting that transcriptional activation by
BMAL1 is coupled with its ubiquitylation. We found that
HDAC3 associates with BMAL1 and that these proteins co-
localize in the nucleus. Depletion of HDAC3 resulted in a marked
reduction of BMAL1 ubiquitylation during the activation phase
(Figure 4C). In contrast, overexpression of HDAC3 led to an in-
crease in BMAL1 ubiquitylation. Although the presence of
HDAC3 results in the accumulation of ubiquitylated BMAL1,
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suggesting that HDAC3 impairs the degradation of ubiquitylated
BMAL1. Together, these results suggest that HDAC3 is required
for efficient activation of E-box-driven transcription by promoting
the accumulation of ubiquitylated BMAL1.
The rhythmic interaction between BMAL1 and CRYs, which
peaks during subjective night, is essential for the negative feed-
back process (Czarna et al., 2011; Kiyohara et al., 2006; Lee
et al., 2001; Sato et al., 2006). However, the mechanism of
this interaction has not been clear (Lee et al., 2001). Here we
show that HDAC3 plays a critical role in mediating the interac-
tion between BMAL1 and CRY1. HDAC3 blocks FBXL3-medi-
ated CRY1 degradation and strongly promotes BMAL1-CRY1
interaction, a process that inhibits BMAL1-CLOCK-dependent
transcription during the repression phase (Figure 7E). Therefore,
HDAC3 has two seemingly opposite functions in the circadian
negative feedback loop: to enhance E-box-driven transcription
and to repress the activity of BMAL1. However, these two func-
tions of HDAC3 are separated temporally. The effect of HDAC3
on BMAL1 accumulation and on E-box-driven transcription
occurs primarily during subjective day (CT 4–12), whereas its
effect on the BMAL1-CRY interaction is primarily limited to
subjective night (CT 16–24). Such a mechanism allows for
maximum activation of E-box-driven transcription during the
activation phase while also maximally repressing transcription
during the repression phase, resulting in high-amplitude circa-
dian rhythms.
The effect of HDAC3 on CRYs is mediated by FBXL3, the
E3 ligase that mediates the ubiquitylation and degradation of
CRY1 (Busino et al., 2007; Godinho et al., 2007; Siepka et al.,
2007). FBXL3 interacts with HDAC3 and strongly promotes its
association with CRYs. In addition, because HDAC3 blocks
FBXL3-mediated CRY degradation, CRY levels are low when
HDAC3 is depleted (Figure 2B). Therefore, both the stabilization
of CRYs and the ability of HDAC3 to associate with both BMAL1
and CRYs can contribute the dramatic effect of HDAC3 on
BMAL1-CRY association (Figure 7E). The mechanism for the
temporal regulation of HDAC3 functions is currently unclear.
Both BMAL1 and FBXL3 are subjected to rhythmic post-transla-
tional modifications. It is possible that such rhythmic modifica-
tions may affect the circadian phase-dependent functions of
HDAC3.
HDAC3 has been shown previously to be recruited by REV-
ERBa to direct rhythmic histone deacetylation (peaking at
approximately CT 10), a process thought to be important forFigure 7. The Effect of HDAC3 on BMAL1 and CRY1 Is Independent of
(A) The interaction between HA-BMAL1 and HA-HDAC3 or the ubiquitylation of B
HDAC3, HDAC3 (S424A), or HDAC3 (H134Q/H135A/A136S). IPs were performed
was performed using anti-HA, anti-HDAC3, anti-BMAL1, or anti-ubiquitin antibod
(B) Per2luc MEFs were transfected with GFP-expressing (blue), mutant HDAC3 (S
adenoviruses for 60 hr and synchronized with a DEX shock as described in Figure
**p < 0.001, * < 0.05.
(C) The interaction between FLAG-BMAL1 andHA-CRY1wasmeasured in the pre
HEK293T cells. The IPs were performed with an anti-BMAL1 antibody, and subse
antibody.
(D) In vivo ubiquitylation assay of CRY1. HA-CRY1, HA-HDAC3, PER2, and FBXL3
The anti-CRY1 antibody immunoprecipitate was immunoblotted with anti-ubiqui
(E) Model of the deacetylase-independent activity of HDAC3 with respect to the a
The gray circle represents ubiquitylated BMAL1.
832 Cell Reports 14, 823–834, February 2, 2016 ª2016 The Authorscircadian output (Feng et al., 2011; Yin and Lazar, 2005). Such
a role of HDAC3 is dependent on its histone deacetylase activity.
However, the two roles of HDAC3 in the core circadian negative
feedback loop are deacetylase activity-independent. Catalyti-
cally dead HDAC3 can still promote both E-box-driven tran-
scription and the interaction between BMAL1 and CRYs. These




Fbxl3/ mice have been described previously (Shi et al., 2013), and the Alb-
Cre transgenic mice were obtained from The Jackson Laboratory (stock no.
003574). The Per2Luc mice were provided by Dr. Joseph Takahashi (University
of Texas Southwestern Medical Center). To generate Hdac3-floxed mice,
EUCOMM B6 embryonic stem cells (ESCs) were injected into blastocysts,
and the resulting chimeric males were bred to C57BL/6J mice by following
standard protocols. Hdac1- and Hdac2-floxed animals were obtained from
the International Mouse Phenotyping Consortium (IMPC). For FH-Fbxl3
mice, a BAC clone (bMQ186h21) was modified with a 33 FLAG-HA tag
sequence inserted into the position corresponding to the N terminus of the
Fbxl3 coding region. Modified BACs were purified and injected into fertilized
eggs to obtain BAC transgenic founders. All animal studies were carried out
in an Association for Assessment and Accreditation of Laboratory Animal
Care internationally accredited specific pathogen-free animal facility, and all
animal protocols were approved by the Animal Care and Use Committee of
the Model Animal Research Center, the host for the National Resource Center
for Mutant Mice in China, Nanjing University.
Luminescence Recording
The detailedmethods for real-timemeasurement of luminescence from ex vivo
tissues have been described previously (Liu et al., 2014; Yamazaki and Taka-
hashi, 2005). For each genotype, 3–4 mice with 19–21 slices were examined.
The MEFs from PER2::LUC mice (Yoo et al., 2004) were used at passages 3–4
and infected with recombinant adenovirus (GFP as a control, HDAC3, HDAC3
(H134Q/H135A/A136S), or HDACS424A) according to the experiment de-
signs. 48–60 hr after infection, the cells were synchronized by DEX, and biolu-
minescence was recorded in real time with the LumiCycle (LumiCycle, Acti-
metrics). We previously developed a program (Liu et al., 2014) based on that
of a method described previously (Izumo et al., 2006). This program allowed
us to run the LumiCycle data to obtain a mean trend by a self-step algorithm.
After subtracting the mean trend from the raw data and removing the damping
effects, we used fast Fourier transform nonlinear least-squares (FFT-NLLS) to
estimate the period and phase of the rhythms. The estimate of amplitude was
then determined by a linear least-squares estimation of the detrended data.
The normalized amplitude between cycles 2 and 4 was calculated by dividing
the amplitude estimate by the average of luminescence intensity and was ex-
pressed as a fractional value.Its Deacetylase Activity and PER2
MAL1 by HDAC3 was measured in the presence or absence of cotransfected
with an anti-BMAL1 antibody, and subsequent detection of HDAC3 or BMAL1
ies as indicated.
424A)-expressing (black), or HDAC3 (H134Q/H135A/A136S)-expressing (red)
1C. Right: normalized amplitudes (n = 8 from three independent experiments).
sence or absence of cotransfected HA-HDAC3, HA-CLOCK, FBXL3, or PER2 in
quent detection of CRY1, CLOCK, and HDAC3 was conducted with an anti-HA
were expressed in HEK293T cells. The cells were lysed 24 hr after transfection.
tin and anti-CRY1 antibodies.
ctivation and repression phases of the circadian clock. B, BMAL1; C, CLOCK.
Statistical Analysis
One-way or twoway ANOVA followed by t test was performed usingGraphPad
Prism software to determine the significant differences between different
genotypes. p < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.12.076.
AUTHOR CONTRIBUTIONS
G.S., P.X., and Y.X. contributed to the experimental design, work, and data
analysis. Z.Q., Z.Z., Z.D., L.X., Z.L., Y.A., and Y.D. contributed to the mouse
work. G.X., L.Y., and Y.L. provided intellectual input. Y.L. assisted with the
data analysis. G.S., Y.L., and Y.X. wrote the manuscript.
ACKNOWLEDGMENTS
We thank Dr. Guanghui Wang, Dr. Guocun Huang, and members of the Y.X.
laboratory for assistance. This work was supported by grants 31230049 and
31171343 from the National Science Foundation of China (to Y.X.), Ministry
of Science and Technology grant 2013CB945203 (to Y.X.), the priority
Academic Development of Jiangsu Higher Education Institutions, the NIH
(GM068496 to Y.L.), and Welch Foundation grant I-1560 (to Y.L.).
Received: June 11, 2015
Revised: October 11, 2015
Accepted: December 15, 2015
Published: January 14, 2016
REFERENCES
Alenghat, T., Meyers, K., Mullican, S.E., Leitner, K., Adeniji-Adele, A., Avila, J.,
Bucan, M., Ahima, R.S., Kaestner, K.H., and Lazar, M.A. (2008). Nuclear re-
ceptor corepressor and histone deacetylase 3 govern circadian metabolic
physiology. Nature 456, 997–1000.
Bass, J., and Takahashi, J.S. (2010). Circadian integration of metabolism and
energetics. Science 330, 1349–1354.
Bhaskara, S., Chyla, B.J., Amann, J.M., Knutson, S.K., Cortez, D., Sun, Z.W.,
and Hiebert, S.W. (2008). Deletion of histone deacetylase 3 reveals critical
roles in S phase progression and DNA damage control. Mol. Cell 30, 61–72.
Brown, S.A., Ripperger, J., Kadener, S., Fleury-Olela, F., Vilbois, F., Rosbash,
M., and Schibler, U. (2005). PERIOD1-associated proteins modulate the nega-
tive limb of the mammalian circadian oscillator. Science 308, 693–696.
Bunger, M.K., Wilsbacher, L.D., Moran, S.M., Clendenin, C., Radcliffe, L.A.,
Hogenesch, J.B., Simon, M.C., Takahashi, J.S., and Bradfield, C.A. (2000).
Mop3 is an essential component of the master circadian pacemaker in mam-
mals. Cell 103, 1009–1017.
Busino, L., Bassermann, F., Maiolica, A., Lee, C., Nolan, P.M., Godinho, S.I.,
Draetta, G.F., and Pagano, M. (2007). SCFFbxl3 controls the oscillation of
the circadian clock by directing the degradation of cryptochrome proteins.
Science 316, 900–904.
Cardone, L., Hirayama, J., Giordano, F., Tamaru, T., Palvimo, J.J., and
Sassone-Corsi, P. (2005). Circadian clock control by SUMOylation of
BMAL1. Science 309, 1390–1394.
Chen, R., Schirmer, A., Lee, Y., Lee, H., Kumar, V., Yoo, S.H., Takahashi, J.S.,
and Lee, C. (2009). Rhythmic PER abundance defines a critical nodal point
for negative feedback within the circadian clock mechanism. Mol. Cell 36,
417–430.
Czarna, A., Breitkreuz, H., Mahrenholz, C.C., Arens, J., Strauss, H.M., and
Wolf, E. (2011). Quantitative analyses of cryptochrome-mBMAL1 interactions:
mechanistic insights into the transcriptional regulation of the mammalian
circadian clock. J. Biol. Chem. 286, 22414–22425.CDuong, H.A., and Weitz, C.J. (2014). Temporal orchestration of repressive
chromatin modifiers by circadian clock Period complexes. Nat. Struct. Mol.
Biol. 21, 126–132.
Duong, H.A., Robles, M.S., Knutti, D., and Weitz, C.J. (2011). A molecular
mechanism for circadian clock negative feedback. Science 332, 1436–1439.
Feng, D., Liu, T., Sun, Z., Bugge, A., Mullican, S.E., Alenghat, T., Liu, X.S., and
Lazar, M.A. (2011). A circadian rhythm orchestrated by histone deacetylase 3
controls hepatic lipid metabolism. Science 331, 1315–1319.
Godinho, S.I., Maywood, E.S., Shaw, L., Tucci, V., Barnard, A.R., Busino, L.,
Pagano, M., Kendall, R., Quwailid, M.M., Romero, M.R., et al. (2007). The af-
ter-hours mutant reveals a role for Fbxl3 in determining mammalian circadian
period. Science 316, 897–900.
Griffin, E.A., Jr., Staknis, D., and Weitz, C.J. (1999). Light-independent role of
CRY1 and CRY2 in the mammalian circadian clock. Science 286, 768–771.
Hardin, P.E., and Panda, S. (2013). Circadian timekeeping and output mecha-
nisms in animals. Curr. Opin. Neurobiol. 23, 724–731.
Hirano, A., Yumimoto, K., Tsunematsu, R., Matsumoto, M., Oyama, M., Ko-
zuka-Hata, H., Nakagawa, T., Lanjakornsiripan, D., Nakayama, K.I., and Fu-
kada, Y. (2013). FBXL21 regulates oscillation of the circadian clock through
ubiquitination and stabilization of cryptochromes. Cell 152, 1106–1118.
Hirayama, J., Sahar, S., Grimaldi, B., Tamaru, T., Takamatsu, K., Nakahata, Y.,
and Sassone-Corsi, P. (2007). CLOCK-mediated acetylation of BMAL1 con-
trols circadian function. Nature 450, 1086–1090.
Izumo, M., Sato, T.R., Straume, M., and Johnson, C.H. (2006). Quantitative
analyses of circadian gene expression in mammalian cell cultures. PLoS Com-
put. Biol. 2, e136.
Kiyohara, Y.B., Tagao, S., Tamanini, F., Morita, A., Sugisawa, Y., Yasuda, M.,
Yamanaka, I., Ueda, H.R., van der Horst, G.T., Kondo, T., and Yagita, K. (2006).
The BMAL1 C terminus regulates the circadian transcription feedback loop.
Proc. Natl. Acad. Sci. USA 103, 10074–10079.
Knutson, S.K., Chyla, B.J., Amann, J.M., Bhaskara, S., Huppert, S.S., and Hie-
bert, S.W. (2008). Liver-specific deletion of histone deacetylase 3 disrupts
metabolic transcriptional networks. EMBO J. 27, 1017–1028.
Koike, N., Yoo, S.H., Huang, H.C., Kumar, V., Lee, C., Kim, T.K., and Takaha-
shi, J.S. (2012). Transcriptional architecture and chromatin landscape of the
core circadian clock in mammals. Science 338, 349–354.
Kornmann, B., Schaad, O., Bujard, H., Takahashi, J.S., and Schibler, U. (2007).
System-driven and oscillator-dependent circadian transcription in mice with a
conditionally active liver clock. PLoS Biol. 5, e34.
Kume, K., Zylka, M.J., Sriram, S., Shearman, L.P., Weaver, D.R., Jin, X., May-
wood, E.S., Hastings,M.H., and Reppert, S.M. (1999). mCRY1 andmCRY2 are
essential components of the negative limb of the circadian clock feedback
loop. Cell 98, 193–205.
Kwon, I., Lee, J., Chang, S.H., Jung, N.C., Lee, B.J., Son, G.H., Kim, K., and
Lee, K.H. (2006). BMAL1 shuttling controls transactivation and degradation
of the CLOCK/BMAL1 heterodimer. Mol. Cell. Biol. 26, 7318–7330.
Langmesser, S., Tallone, T., Bordon, A., Rusconi, S., and Albrecht, U. (2008).
Interaction of circadian clock proteins PER2 and CRY with BMAL1 and
CLOCK. BMC Mol. Biol. 9, 41.
Lee, C., Etchegaray, J.P., Cagampang, F.R., Loudon, A.S., and Reppert, S.M.
(2001). Posttranslational mechanisms regulate the mammalian circadian
clock. Cell 107, 855–867.
Lee, J., Lee, Y., Lee, M.J., Park, E., Kang, S.H., Chung, C.H., Lee, K.H., and
Kim, K. (2008). Dual modification of BMAL1 by SUMO2/3 and ubiquitin pro-
motes circadian activation of the CLOCK/BMAL1 complex. Mol. Cell. Biol.
28, 6056–6065.
Liu, Z., Huang, M., Wu, X., Shi, G., Xing, L., Dong, Z., Qu, Z., Yan, J., Yang, L.,
Panda, S., and Xu, Y. (2014). PER1 phosphorylation specifies feeding rhythm
in mice. Cell Rep. 7, 1509–1520.
Lowrey, P.L., and Takahashi, J.S. (2004). Mammalian circadian biology: eluci-
dating genome-wide levels of temporal organization. Annu. Rev. Genomics
Hum. Genet. 5, 407–441.ell Reports 14, 823–834, February 2, 2016 ª2016 The Authors 833
Lowrey, P.L., and Takahashi, J.S. (2011). Genetics of circadian rhythms in
Mammalian model organisms. Adv. Genet. 74, 175–230.
Matsumura, R., Tsuchiya, Y., Tokuda, I., Matsuo, T., Sato, M., Node, K., Nish-
ida, E., and Akashi, M. (2014). The mammalian circadian clock protein period
counteracts cryptochrome in phosphorylation dynamics of circadian locomo-
tor output cycles kaput (CLOCK). J. Biol. Chem. 289, 32064–32072.
Miki, T., Xu, Z., Chen-Goodspeed, M., Liu, M., Van Oort-Jansen, A., Rea, M.A.,
Zhao, Z., Lee, C.C., and Chang, K.S. (2012). PML regulates PER2 nuclear
localization and circadian function. EMBO J. 31, 1427–1439.
Nakahata, Y., Kaluzova, M., Grimaldi, B., Sahar, S., Hirayama, J., Chen, D.,
Guarente, L.P., and Sassone-Corsi, P. (2008). The NAD+-dependent deacety-
lase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian
control. Cell 134, 329–340.
Nangle, S.N., Rosensweig, C., Koike, N., Tei, H., Takahashi, J.S., Green, C.B.,
and Zheng, N. (2014). Molecular assembly of the period-cryptochrome circa-
dian transcriptional repressor complex. eLife 3, e03674.
Padmanabhan, K., Robles, M.S., Westerling, T., and Weitz, C.J. (2012). Feed-
back regulation of transcriptional termination by the mammalian circadian
clock PERIOD complex. Science 337, 599–602.
Partch, C.L., Green, C.B., and Takahashi, J.S. (2014). Molecular architecture of
the mammalian circadian clock. Trends Cell Biol. 24, 90–99.
Postic, C., and Magnuson, M.A. (2000). DNA excision in liver by an albumin-
Cre transgene occurs progressively with age. Genesis 26, 149–150.
Preitner, N., Damiola, F., Lopez-Molina, L., Zakany, J., Duboule, D., Albrecht,
U., and Schibler, U. (2002). The orphan nuclear receptor REV-ERBalpha con-
trols circadian transcription within the positive limb of the mammalian circa-
dian oscillator. Cell 110, 251–260.
Reppert, S.M., and Weaver, D.R. (2002). Coordination of circadian timing in
mammals. Nature 418, 935–941.
Ripperger, J.A., and Schibler, U. (2006). Rhythmic CLOCK-BMAL1 binding to
multiple E-box motifs drives circadian Dbp transcription and chromatin transi-
tions. Nat. Genet. 38, 369–374.
Sato, T.K., Panda, S., Miraglia, L.J., Reyes, T.M., Rudic, R.D., McNamara, P.,
Naik, K.A., FitzGerald, G.A., Kay, S.A., and Hogenesch, J.B. (2004). A func-
tional genomics strategy reveals Rora as a component of the mammalian
circadian clock. Neuron 43, 527–537.
Sato, T.K., Yamada, R.G., Ukai, H., Baggs, J.E., Miraglia, L.J., Kobayashi, T.J.,
Welsh, D.K., Kay, S.A., Ueda, H.R., and Hogenesch, J.B. (2006). Feedback
repression is required for mammalian circadian clock function. Nat. Genet.
38, 312–319.
Schibler, U., and Naef, F. (2005). Cellular oscillators: rhythmic gene expression
and metabolism. Curr. Opin. Cell Biol. 17, 223–229.
Shearman, L.P., Sriram, S., Weaver, D.R., Maywood, E.S., Chaves, I., Zheng,
B., Kume, K., Lee, C.C., van der Horst, G.T., Hastings, M.H., and Reppert, S.M.
(2000). Interacting molecular loops in the mammalian circadian clock. Science
288, 1013–1019.
Shi, G., Xing, L., Liu, Z., Qu, Z., Wu, X., Dong, Z., Wang, X., Gao, X., Huang, M.,
Yan, J., et al. (2013). Dual roles of FBXL3 in the mammalian circadian feedback
loops are important for period determination and robustness of the clock.
Proc. Natl. Acad. Sci. USA 110, 4750–4755.
Siepka, S.M., Yoo, S.H., Park, J., Song, W., Kumar, V., Hu, Y., Lee, C., and Ta-
kahashi, J.S. (2007). Circadian mutant Overtime reveals F-box protein FBXL3
regulation of cryptochrome and period gene expression. Cell 129, 1011–1023.
Stratmann, M., Suter, D.M., Molina, N., Naef, F., and Schibler, U. (2012). Circa-
dian Dbp transcription relies on highly dynamic BMAL1-CLOCK interaction
with E Boxes and requires the proteasome. Mol. Cell 48, 277–287.
Sun, Z., Feng, D., Fang, B., Mullican, S.E., You, S.H., Lim, H.W., Everett, L.J.,
Nabel, C.S., Li, Y., Selvakumaran, V., et al. (2013). Deacetylase-independent834 Cell Reports 14, 823–834, February 2, 2016 ª2016 The Authorsfunction of HDAC3 in transcription and metabolism requires nuclear receptor
corepressor. Mol. Cell 52, 769–782.
Tamaru, T., Isojima, Y., van der Horst, G.T., Takei, K., Nagai, K., and Taka-
matsu, K. (2003). Nucleocytoplasmic shuttling and phosphorylation of
BMAL1 are regulated by circadian clock in cultured fibroblasts. Genes Cells
8, 973–983.
Tamaru, T., Hirayama, J., Isojima, Y., Nagai, K., Norioka, S., Takamatsu, K.,
and Sassone-Corsi, P. (2009). CK2alpha phosphorylates BMAL1 to regulate
the mammalian clock. Nat. Struct. Mol. Biol. 16, 446–448.
Ueda, H.R., Hayashi, S., Chen,W., Sano, M., Machida, M., Shigeyoshi, Y., Iino,
M., and Hashimoto, S. (2005). System-level identification of transcriptional cir-
cuits underlying mammalian circadian clocks. Nat. Genet. 37, 187–192.
Ukai-Tadenuma, M., Yamada, R.G., Xu, H., Ripperger, J.A., Liu, A.C., and
Ueda, H.R. (2011). Delay in feedback repression by cryptochrome 1 is required
for circadian clock function. Cell 144, 268–281.
Watson, P.J., Fairall, L., Santos, G.M., and Schwabe, J.W. (2012). Structure of
HDAC3 bound to co-repressor and inositol tetraphosphate. Nature 481,
335–340.
Wen, Y.D., Cress, W.D., Roy, A.L., and Seto, E. (2003). Histone deacetylase 3
binds to and regulates the multifunctional transcription factor TFII-I. J. Biol.
Chem. 278, 1841–1847.
Xing, W., Busino, L., Hinds, T.R., Marionni, S.T., Saifee, N.H., Bush, M.F., Pa-
gano, M., and Zheng, N. (2013). SCF(FBXL3) ubiquitin ligase targets crypto-
chromes at their cofactor pocket. Nature 496, 64–68.
Yagita, K., Tamanini, F., Yasuda, M., Hoeijmakers, J.H., van der Horst, G.T.,
and Okamura, H. (2002). Nucleocytoplasmic shuttling and mCRY-dependent
inhibition of ubiquitylation of the mPER2 clock protein. EMBO J. 21, 1301–
1314.
Yamazaki, S., and Takahashi, J.S. (2005). Real-time luminescence reporting
of circadian gene expression in mammals. Methods Enzymol. 393, 288–301.
Ye, R., Selby, C.P., Ozturk, N., Annayev, Y., and Sancar, A. (2011). Biochem-
ical analysis of the canonical model for the mammalian circadian clock. J. Biol.
Chem. 286, 25891–25902.
Ye, R., Selby, C.P., Chiou, Y.Y., Ozkan-Dagliyan, I., Gaddameedhi, S., and
Sancar, A. (2014). Dual modes of CLOCK:BMAL1 inhibition mediated by Cryp-
tochrome and Period proteins in the mammalian circadian clock. Genes Dev.
28, 1989–1998.
Yin, L., and Lazar, M.A. (2005). The orphan nuclear receptor Rev-erbalpha re-
cruits the N-CoR/histone deacetylase 3 corepressor to regulate the circadian
Bmal1 gene. Mol. Endocrinol. 19, 1452–1459.
Yoo, S.H., Yamazaki, S., Lowrey, P.L., Shimomura, K., Ko, C.H., Buhr, E.D.,
Siepka, S.M., Hong, H.K., Oh, W.J., Yoo, O.J., et al. (2004). PERIOD2:
LUCIFERASE real-time reporting of circadian dynamics reveals persistent
circadian oscillations in mouse peripheral tissues. Proc. Natl. Acad. Sci.
USA 101, 5339–5346.
Yoo, S.H., Ko, C.H., Lowrey, P.L., Buhr, E.D., Song, E.J., Chang, S., Yoo, O.J.,
Yamazaki, S., Lee, C., and Takahashi, J.S. (2005). A noncanonical E-box
enhancer drives mouse Period2 circadian oscillations in vivo. Proc. Natl.
Acad. Sci. USA 102, 2608–2613.
Yoo, S.H., Mohawk, J.A., Siepka, S.M., Shan, Y., Huh, S.K., Hong, H.K.,
Kornblum, I., Kumar, V., Koike, N., Xu, M., et al. (2013). Competing E3 ubiquitin
ligases govern circadian periodicity by degradation of CRY in nucleus and
cytoplasm. Cell 152, 1091–1105.
Zhang, X., Ozawa, Y., Lee, H., Wen, Y.D., Tan, T.H., Wadzinski, B.E., and Seto,
E. (2005). Histone deacetylase 3 (HDAC3) activity is regulated by interaction
with protein serine/threonine phosphatase 4. Genes Dev. 19, 827–839.
